Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels

Local Delivery of the K Ca 3.1 Blocker, TRAM-34, Prevents Acute Angioplasty-Induced Coronary Smooth Muscle Phenotypic Modulation and Limits Stenosis

(2008) D.L. Tharp et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia

(2008) K. I. Ataga et al.   BLOOD

Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat

(2008) Nicolas Picard et al.   HISTOCHEMISTRY AND CELL BIOLOGY

The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans

(2008) Kazuyoshi Toyama et al.   JOURNAL OF CLINICAL INVESTIGATION

Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition

(2008) E. M. Zeisberg et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Mitogenic modulation of Ca2+-activated K+ channels in proliferating A7r5 vascular smooth muscle cells

(2006) Han Si et al.   BRITISH JOURNAL OF PHARMACOLOGY